Serological Response to Vaccination after Autologous Transplantation for Multiple Myeloma Is Associated with Improved Progression-Free and Overall Survival-Reference-Cited by-同舟云学术

Serological Response to Vaccination after Autologous Transplantation for Multiple Myeloma Is Associated with Improved Progression-Free and Overall Survival

Published:2021-03 Issue:3 Volume:27 Page:245.e1-245.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Merz Almuth M.A.,Merz Maximilian,Zhang Yali,Stecklein Kathryn,Pleskow Jordan,Chen George L.,Buck Dennis A.,Mohammadpour Hemn,Herr Megan M.,Elshoury Amro,Hillengass Jens,McCarthy Philip L.,Hahn Theresa

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference28 articles.

1. Multiple myeloma;Röllig;Lancet,2015

2. Vaccination of hematopoietic cell transplant recipients;Ljungman;Bone Marrow Transplant,2009

3. Guidelines for preventing infectiouscomplications among hematopoietic cell transplantation recipients: a global perspective;Tomblyn;Biol Blood Marrow Transplant,2009

4. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host;Rubin;Clin Infect Dis,2014

5. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation;Antin;Biol Blood Marrow Transplant,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitators and Barriers to Successful Revaccination after Hematopoietic Stem Cell Transplantation among Adult Survivors: A Scoping Review;Transplantation and Cellular Therapy;2023-11

2. High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post–Autologous Stem Cell Transplant Period;Open Forum Infectious Diseases;2023-09-30

3. A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022;Expert Review of Anticancer Therapy;2022-05-03

4. The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma;Transplantation and Cellular Therapy;2021-10